Anton V Tverdokhlebov

Title: Anton V Tverdokhlebov: Innovator in Therapeutics

Introduction

Anton V Tverdokhlebov is a notable inventor based in Poltava, Ukraine. He has made significant contributions to the field of therapeutics, particularly in the development of compounds targeting the human androgen receptor.

Latest Patents

Tverdokhlebov holds a patent for "Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use." This patent describes a compound with a specific structure, where A is a substituted or unsubstituted aryl or heteroaryl group, D is a substituted or unsubstituted 5- or 6-membered heteroaryl or heterocyclyl group, and E is a substituted or unsubstituted aryl, heteroaryl, cycloalkyl, or heterocyclyl group. The compounds are intended for the treatment of various androgen-modulated conditions, including prostate, breast, ovarian, endometrial, or bladder cancer, hair loss, acne, hirsutism, ovarian cysts, polycystic ovary disease, precocious puberty, and age-related macular degeneration. The patent also covers the use of these compounds for manufacturing medicaments that modulate androgen receptor activity.

Career Highlights

Tverdokhlebov is affiliated with the University of British Columbia, where he continues to advance his research in the field of therapeutics. His work has led to the development of innovative solutions for significant health issues.

Collaborations

He has collaborated with notable colleagues, including Artem Tcherkassov and Paul Rennie, to further enhance the impact of his research and inventions.

Conclusion

Anton V Tverdokhlebov is a distinguished inventor whose work in developing androgen receptor-targeting compounds holds promise for treating various medical conditions. His contributions to the field of therapeutics are noteworthy and continue to influence future research and development.